Colleen Plein, MD
Otolaryngology · Kenosha, WINPI 1114248028
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 45.1% of the total. Reporting peaked in 2024 at $7,761 and has fallen 77.1% since, to $1,774 in 2025. Among otolaryngology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 312 payments — averaging $52.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$7K
- Optinose US, Inc.$3K
- GSK$2K
- Sanofi$1K
- Intersect ENT, Inc.$563
- Medtronic$518
- plus $1K from 13 others
What the payments were for
- Consulting fees$8,04649%
- Travel & lodging$1,3578%
- Food & beverage$6,65441%
- Education$2171%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 58 | $7,344 |
| Optinose US, Inc. | 46 | $3,484 |
| GSK | 91 | $1,667 |
| Sanofi | 47 | $1,256 |
| Intersect ENT, Inc. | 10 | $563 |
| Medtronic(2 entities) | 10 | $518 |
| Aerin Medical Inc. | 9 | $329 |
| Stryker | 14 | $321 |
| Alk-abello, Inc | 9 | $263 |
| Watermark Medical, Inc. | 1 | $119 |
| Acclarent, Inc | 4 | $91 |
| AstraZeneca | 4 | $87 |
| Sanofi-aventis U.S. LLC | 1 | $53 |
| Smith+Nephew | 2 | $53 |
| Amgen | 2 | $33 |
| Neurent Medical Limited | 1 | $32 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Vertex | 1 | $23 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$6,892
- Xhance$2,687
- ARES HOME SLEEP TESTING DEVICE$119
- NUCALA$115
- PROPEL$101
How this compares
$16,273 in reported general payments places this provider in the 95th percentile of 168 otolaryngology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 15 | $56,804 |
| Ipratropium Bromide | 44 | $1,119 |
| Fluticasone Propionate | 49 | $662 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Kenosha
- Hilel SwerdlinKenosha$8K
- Jason BrantMadison$103K
- B WoodsonMilwaukee$45K
- Thomas Gessertla Crosse$21K
- Steven SperryGreenfield$13K
- David PoetkerMilwaukee$13K
- Michael OldenburgGreen Bay$8K
- Jamal AhmedMarshfield$8K
- Michelle MarkMadison$6K
- Madan KandulaMilwaukee$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.